Main Menu

Video: Technology development at the cutting edge of fundamental biology

As our Head of Cancer Biology, Professor Jon Pines leads the fundamental biology research at the top-ranked higher education institute for Biological Sciences in the UK. At the ICR, world-class scientists work in a culture that encourages commercial collaborations and which has led to the ICR regularly ranking close to the top worldwide in rankings that measure effective collaboration with industry.

Professor Pines’ research focuses on understanding how cells divide, using cutting-edge microscopy techniques to figure out how the molecular machinery that controls this process is regulated in time and space. His pioneering discoveries to understand cell division and how it can go wrong in cancer led to his election as a Fellow of the Royal Society in 2016.

Professor Pines’ team hopes to uncover new molecular targets for the design of drugs to treat cancer. His team use state-of-the-art imaging technologies to study the inner workings of cells in unprecedented detail – down to the level of molecules within single cells. They collaborate with companies to develop new equipment and novel techniques that can help them to push the boundaries further than ever before.

Current collaborations include working with Intelligent Imaging Innovations to develop pioneering technology in lattice-sheet microscopy.

Watch more videos of our researchers

Working with pharmaceutical companies

Dr Marco Gerlinger talking about working with pharmaceutical companies

Dr Marco Gerlinger's Translational Oncogenomics Team are keen to develop new partnerships to continue their work, and to access drugs that could reverse the resistance mechanisms that the team has identified so far.


New partnerships in cancer epigenetics

Professor Jessica Downs

Our Epigenetics and Genome Stability team, led by Professor Jessica Downs, is working on a variety of research programmes that could be developed in collaboration with commercial partners.


Sharing experience with industry partners

Dr Paul Huang

Our Molecular and Systems Oncology Team, led by Dr Paul Huang, is keen to collaborate with industry partners on a number of projects on biochemistry, computational modelling, molecular pathology and proteomics.


Collaborating with commercial partners

Dr Anguraj Sadanandam

Our Systems and Precision Cancer Medicine team, led by Dr Anguraj Sadanandam, is investigating ways to stratify tumours based on their genetic and clinical diversity.


Exploring new opportunities for collaborative working

Professor Uwe Oelfke

Professor Uwe Oelfke, Deputy Head of the Division of Radiotherapy and Imaging, is keen to explore new opportunities for collaborative working with industry.


The benefits of partnering with industry

Dr Igor Vivanco

Our Molecular Addictions team, led by Dr Igor Vivanco, is working on a variety of projects that could be developed in collaboration with commercial partners.


Connections newsletter

Sign up to our new quarterly newsletter for updates on our Business and Innovation Office and news about working with industry.